It is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1)
receptor agonist that is being developed for the treatment of type 2 diabetes. It shows significantly better 
efficacy with regard to glucose control.
This content is provided strictly for research purposes and does not constitute an endorsement or 
recommendation for the non-laboratory application or improper handling of peptides designed for research. 
The information, including discussions about specific peptides and their researched benefits, is presented for informational purposes only and must not be construed as health, clinical, or legal guidance, nor an encouragement for non-research use in humans.
Peptides described here are solely for use in structured scientific study by authorized individuals.

For research USE ONLY.

---

Our factory

“Strength builds the foundation, and excellent services reach all over the world.” Create win-win situation with customers